OACC

Index	-
Market Cap	264.26M
Enterprise Value	263.09M
Income	6.75M
Sales	0.00M
Book/sh	8.05
Cash/sh	0.05
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	3
IPO	Dec 16, 2024

P/E	39.12
Forward P/E	-
PEG	-
P/S	-
P/B	1.34
P/C	223.95
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.73
Current Ratio	0.73
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	0.27
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	39.00%
Sales Y/Y TTM	-
EPS Q/Q	-14.30%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	19.52%
Insider Trans	0.00%
Inst Own	80.01%
Inst Trans	-
ROA	3.33%
ROE	3.47%
ROIC	3.41%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-0.15%
SMA50	0.17%
SMA200	1.25%
Trades

Shs Outstand	19.78M
Shs Float	19.78M
Short Float	0.00%
Short Ratio	0.00
Short Interest	0.00M
52W High	10.88 -1.15%
52W Low	10.50 2.38%
Volatility	0.08% 0.21%
ATR (14)	0.04
RSI (14)	48.64
Beta	-0.01
Rel Volume	13.31
Avg Volume	58.90K
Volume	85,004

Perf Week	-0.09%
Perf Month	-0.14%
Perf Quarter	0.56%
Perf Half Y	0.94%
Perf YTD	1.61%
Perf Year	1.70%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	10.76
Price	10.75
Change %	-0.09%

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.

CEO & DirectorMr. Zaid Pardesi

CFOMr. George A. Martinez

Chief Operation OfficerMr. Mathew M. Pendo

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Oaktree Acquisition Corp III Life Sciences

Upgrade your Finviz experience